Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamir R Mehta

Showing results (191-200 of 212) with videos related to

Pageof 22
Sort By:
International Journal of Cardiology|April 20, 2023
Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHTAlessandro Spirito, Marco Valgimigli, Davide Cao, et al.
The American Journal of Cardiology|March 6, 2024
SYNERGY-Everolimus-Eluting Stent With a Bioabsorbable Polymer in ST-Elevation Myocardial Infarction: CLEAR SYNERGY OASIS-9 RegistrySanjit S Jolly, Shun Fu Lee, Rajibul Mian, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 6, 2023
Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trialMarc-André d'Entremont, Sulaiman Alrashidi, Omar Alansari, et al.
Journal of the American College of Cardiology|October 29, 2024
Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-Year Outcomes From the TRILUMINATE Randomized CohortGilbert H L Tang, Rebecca T Hahn, Brian K Whisenant, et al.
The New England Journal of Medicine|November 18, 2024
Colchicine in Acute Myocardial InfarctionSanjit S Jolly, Marc-André d'Entremont, Shun Fu Lee, et al.
Journal of the American College of Cardiology|September 11, 2020
Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary DiseaseTej Sheth, Natalia Pinilla-Echeverri, Raul Moreno, et al.
JAMA Cardiology|May 15, 2021
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical TrialBirgit Vogel, Usman Baber, David J Cohen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2025
Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trialMauro Gitto, Usman Baber, Samantha Sartori, et al.
JAMA Cardiology|September 21, 2022
Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical TrialShamir R Mehta, Jia Wang, David A Wood, et al.
American Heart Journal|January 31, 2025
Characterizing high-risk enrollment criteria and impact on clinical outcomes in a large randomized clinical trial: Insights from the TWILIGHT trialPhilippe Gabriel Steg, Johny Nicolas, Usman Baber, et al.
Pageof 22

Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
International Journal of Cardiology|April 20, 2023
Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHTAlessandro Spirito, Marco Valgimigli, Davide Cao, et al.
The American Journal of Cardiology|March 6, 2024
SYNERGY-Everolimus-Eluting Stent With a Bioabsorbable Polymer in ST-Elevation Myocardial Infarction: CLEAR SYNERGY OASIS-9 RegistrySanjit S Jolly, Shun Fu Lee, Rajibul Mian, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 6, 2023
Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trialMarc-André d'Entremont, Sulaiman Alrashidi, Omar Alansari, et al.
Journal of the American College of Cardiology|October 29, 2024
Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-Year Outcomes From the TRILUMINATE Randomized CohortGilbert H L Tang, Rebecca T Hahn, Brian K Whisenant, et al.
The New England Journal of Medicine|November 18, 2024
Colchicine in Acute Myocardial InfarctionSanjit S Jolly, Marc-André d'Entremont, Shun Fu Lee, et al.
Journal of the American College of Cardiology|September 11, 2020
Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary DiseaseTej Sheth, Natalia Pinilla-Echeverri, Raul Moreno, et al.
JAMA Cardiology|May 15, 2021
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical TrialBirgit Vogel, Usman Baber, David J Cohen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2025
Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trialMauro Gitto, Usman Baber, Samantha Sartori, et al.
JAMA Cardiology|September 21, 2022
Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical TrialShamir R Mehta, Jia Wang, David A Wood, et al.
American Heart Journal|January 31, 2025
Characterizing high-risk enrollment criteria and impact on clinical outcomes in a large randomized clinical trial: Insights from the TWILIGHT trialPhilippe Gabriel Steg, Johny Nicolas, Usman Baber, et al.
Pageof 22